Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:688739'
s EV-to-FCF Range Over the Past 10 Years
Min: -12506.41 Med: 60.85 Max: 851.27
Current: 49.86
During the past 13 years, the highest EV-to-FCF of Liaoning Chengda Biotechnology Co was 851.27. The lowest was -12506.41. And the median was 60.85.
SHSE:688739's EV-to-FCF is ranked worse than 77.04% of 318
companies
in the Biotechnology industry
Industry Median: 15.835
vs SHSE:688739: 49.86
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Liaoning Chengda Biotechnology Co (SHSE:688739) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Liaoning Chengda Biotechnology Co's PE Ratio (TTM) for today is calculated as:
Liaoning Chengda Biotechnology Co's share price for today is ¥20.88.
Liaoning Chengda Biotechnology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.100.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Liaoning Chengda Biotechnology Co EV-to-FCF Related Terms
Liaoning Chengda Biotechnology Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688739 vs VRTX, REGN, MRNA: EV-to-FCF Comparison
For the Biotechnology subindustry, Liaoning Chengda Biotechnology Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Liaoning Chengda Biotechnology Co EV-to-FCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Liaoning Chengda Biotechnology Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Liaoning Chengda Biotechnology Co's EV-to-FCF falls into.
Liaoning Chengda Biotechnology Co's current Enterprise Value is ¥3,521 Mil.
Liaoning Chengda Biotechnology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥72 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Liaoning Chengda Biotechnology Co (SHSE:688739) has a EV-to-FCF of 49.05 as of Sep. 01, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Liaoning Chengda Biotechnology Co and its competitors. This is 19% below median its historical median of 60.85. According to the industry distribution chart, Liaoning Chengda Biotechnology Co ranks #245 out of 318 companies in the Biotechnology industry, placing it in the top 77%.
Is Liaoning Chengda Biotechnology Co's EV-to-FCF too high?
Liaoning Chengda Biotechnology Co's current EV-to-FCF of 49.05 is 19% below median its 10-year median of 60.85. The Biotechnology industry median EV-to-FCF is 15.84. Liaoning Chengda Biotechnology Co's value of 49.05 is 209.8% above this industry median. Based on the distribution chart, Liaoning Chengda Biotechnology Co ranks #245 out of 318 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Liaoning Chengda Biotechnology Co has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Liaoning Chengda Biotechnology Co's EV-to-FCF compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Liaoning Chengda Biotechnology Co ranks #245 out of 318 companies for EV-to-FCF. This places Liaoning Chengda Biotechnology Co in the lower half of its industry. The industry median EV-to-FCF is 15.84. Liaoning Chengda Biotechnology Co's value of 49.05 is 209.8% above this benchmark. While the company's 10-year median is 60.85 vs. the industry median of 15.84, Liaoning Chengda Biotechnology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Biotechnology company?
The median EV-to-FCF among Biotechnology companies is 15.84, based on 318 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Liaoning Chengda Biotechnology Co's current EV-to-FCF of 49.05 is 209.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Liaoning Chengda Biotechnology Co and its competitors. For the Biotechnology industry, the median EV-to-FCF is 15.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Liaoning Chengda Biotechnology Co's current EV-to-FCF is 49.05, which is 19% below median its own 10-year median of 60.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Liaoning Chengda Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Liaoning Chengda Biotechnology Co (SHSE:688739) is currently considered Fairly Valued. The stock's GF Value™ is ¥21.72, compared to a current price of ¥20.88 — trading 3.9% below its estimated fair value. The current EV-to-FCF is 49.05, which is 19% below median its 10-year median of 60.85 and 209.8% above the Biotechnology industry median of 15.84. Liaoning Chengda Biotechnology Co's overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Liaoning Chengda Biotechnology Co (SHSE:688739), the current EV-to-FCF is 49.05 as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Liaoning Chengda Biotechnology Co (SHSE:688739) Overvalued in 2026?
Based on GuruFocus' analysis, Liaoning Chengda Biotechnology Co stock appears to be undervalued.
The current stock price of ¥20.88 is trading 3.9% below its estimated GF Value™ of ¥21.72.
GuruFocus considers Liaoning Chengda Biotechnology Co to be Fairly Valued.
Key valuation signals for SHSE:688739:
EV-to-FCF: 49.05 (19% below median its 10-year median of 60.85)
GF Value™: ¥21.72 vs. price of ¥20.88 (3.9% below fair value)
Industry Position: 209.8% above the Biotechnology median (#245 of 318)
No single metric tells the full story. See the SHSE:688739 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688739 has been successfully added to your 
